RNS Number : 4001C
RTW Venture Fund Limited
19 October 2020
LEI: 549300Q7EXQQH6KF7Z84
19 October 2020
RTW Venture Fund Limited
Quarterly Update
RTW Venture Fund Limited (the "Company") is pleased to announce the Fact Sheet for the quarter ended 30 September 2020 is now available on the Company's website in the Document Library Section www.rtwfunds.com/venture-fund.
For Further Information
RTW Investments, LP
+1 (646) 343 9280
Stephanie Sirota, Chief Business Officer
Alexandra Taracanova, PhD, Director of Investor Relations
Julia Enright, Business Development Associate
Ocorian (Company Secretary) +44 (0)1481 742 642
Kevin Smith
J.P. Morgan Cazenove +44 (0)20 7742 4000
William Simmonds
James Bouverat (Sales)
Barclays
+44 (0)20 7623 2323
Tom Swerling
Andrew Tusa
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at
www.rtwfunds.com
for more information.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
UPDBLBDGUBBDGGI
|
